BENEVOLENTAI Stock Impressive Jump On Thursday, Outperforms Market

(VIANEWS) – The Market ended the session with BENEVOLENTAI (BAI.AS) jumping 13.33% to €0.75 on Thursday, following the last session’s upward trend. AEX-Index jumped 0.01% to €884.17, following the last session’s upward trend on what was a somewhat positive trend trading session today. BENEVOLENTAI’s last close was €0.66, 75.19% below its 52-week high of €2.66….

Read More

ATEME Stock 18.83% Up On Thursday

(VIANEWS) – The Market ended the session with ATEME (ATEME.PA) rising 18.83% to €5.30 on Thursday, following the last session’s upward trend. CAC 40 slid 0.02% to €8,151.55, following the last session’s upward trend on what was a somewhat negative trend trading session today. About ATEME ATEME SA, together with its subsidiaries, provides electronic and…

Read More

Artificial Intelligence Successfully Predicts Price Trend Of GENTIAN DIAGNOSTIC And NORBIT

(VIANEWS) – AICapitalize Artificial Intelligence has been accurately guessing the intraday stock prices and making several successful predictions. Via News will publish the daily results of this AI algorithm. If an investor followed the AICapitalize suggestion, yesterday’s AI investment would yield a 0.53% ROI. The table below shows the data. Financial Asset Accuracy Prediction ROI…

Read More

Artificial Intelligence Predicts Next Session’s Price Change For PARETO BANK, HAL TRUST, SBM OFFSHORE

(VIANEWS) – Today, the AICapitalize artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of PARETO BANK PARB.OL, HAL TRUST HAL.AS and others. Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets. AICapitalize provides A.I.-based…

Read More

ULTIMOVACS Stock 26.4% Up On Wednesday

(VIANEWS) – The Market ended the session with ULTIMOVACS (ULTI.OL) jumping 26.4% to kr11.06 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.48% to kr1,349.28. ULTIMOVACS’s last close was kr8.75, 95.1% under its 52-week high of kr178.60. About ULTIMOVACS Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a…

Read More

ULTIMOVACS Soars 26% In Final Hours Of Trading: Investors Bet On Bullish Momentum

(VIANEWS) – On Wednesday, shares of ULTIMOVACS (ULTI.OL) experienced an extraordinary surge with a 26.4% gain to reach kr11.06 by 15:47 EST – continuing their upward trend following two sessions of gains. Meanwhile, the Oslo Bors Benchmark Index_GI saw a rise of 0.42% to reach 1,348.40 and indicative of generally positive trading sessions. Even after…

Read More